TomoTherapy to Announce Fourth-Quarter Results on Wednesday, February 13, 2008
MADISON, Wis. – Jan. 30, 2008 – TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it will release its 2007 fourth-quarter results on Wednesday, Feb. 13, 2008, at 3:00 p.m. CST.
TomoTherapy will hold an investment community conference call on Wednesday, Feb. 13, 2008, beginning at 4:00 p.m. CST. Dr. Fred Robertson, CEO, and Steve Hathaway, CFO, will review fourth-quarter performance and discuss the company’s strategies. To join the conference call, dial #: 1-866-510-0712 (international 1-617-597-5380) and enter passcode 95806532. A replay of the conference call will be available one hour after the call ends through 11:59 p.m. CST on Feb. 15, 2008. To access the replay, dial 1-888-286-8010 (international 1-617-801-6888) and enter passcode 27979452.
For individual investors, a live Webcast of the conference call will be available on the Investor Relations page of TomoTherapy.com. Institutional investors can access the Webcast through a password-protected site www.streetevents.com. An archived Webcast of TomoTherapy’s conference call will be available for two weeks.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company is traded on the NASDAQ Global Select Market under the symbol TOMO.
30 Jan 2008
